MedTrace Logo

NSAIDs in Coronary Artery Disease Patients

NCT01402804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2013-11-11

No results posted yet for this study

Summary

Introduction:

Different groups already showed in retrospective subgroup analyses, that there is an increased risk for cardiovascular events in patients on a simultaneous ASA/NSAID treatment.

Methods:

Light-Transmission aggregometry

Hypothesis:

Simultaneous administration of different NSAIDs and ASA impair the platelet inhibiting effect of ASA.

Conditions

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Principal Investigators

  • Amin Polzin, MD · Klinik für Kariologie, Pneumologie und Angiologie, Universtiätsklinikum Düsseldorf

  • Tobias Zeus, MD · Klinik für Kardiologie, Pneumologie und Angiologie

  • Thomas Hohlfeld, MD · Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Univerität Düsseldorf

  • Malte Kelm, MD · Heinrich-Heine University, Duesseldorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01402804 on ClinicalTrials.gov